Neuromod chief executive Ross O’Neill (right) with Manus  Rogan, managing partner at Fountain Healthcare Partners. Photograph: Nick Bradshaw

Irish tinnitus therapy group Neuromod has raised €10.5 million to fund the company’s expansion. Tinnitus is a chronic condition that is understood to(...)

A Dublin company chasing a cure for one of the most common forms of leukaemia has raised €30 million.

Irish life sciences venture capital group Fountain Healthcare Partners has led a €30 million fundraising for a new company hunting for treatment for o(...)

 Justin Lynch, partner, Fountain Healthcare Partners, Eamon Brady, CEO, Neuravi and John O’Shaughnessy, chairman, Neuravi

Galway medtech firm Neuravi has raised €19 million to continue to commercial rollout and development of a breakthrough therapy for stroke patients. T(...)

AIB is a significant provider of seed capital funding in Ireland. It has committed €90 million to six funds, which have a combined size of €343 million

AIB has committed €15 million to a dedicated life-sciences venture-capital fund managed by Dublin-based Fountain Healthcare Partners. AIB is investing(...)